Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03630094 · ClinicalTrials.gov registry record · Phase 1
Plasma and Intrapulmonary Concentrations Study of WCK 5222
A Phase 1 study, sponsored by Wockhardt.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT03630094 is a Phase 1 study that has completed, run by Wockhardt. The registered enrollment target is 36 participants.
The verdict
NCT03630094, a Phase 1 study, has completed, sponsored by Wockhardt.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
This is a Phase 1, multiple dose, open-label pharmacokinetic study in healthy adult male and female subjects.
Interventions
- DRUG FEP-ZID
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2017-03-31 |
| Est. Completion | 2017-07-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03630094
The ClinicalTrials.gov registry entry for NCT03630094 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wockhardt, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FEP-ZID is the first listed.
NCT03630094 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03630094 about?
NCT03630094 is a clinical study titled "Plasma and Intrapulmonary Concentrations Study of WCK 5222". This is a Phase 1, multiple dose, open-label pharmacokinetic study in healthy adult male and female subjects.
What is the current status of trial NCT03630094?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2017-03-31. Estimated completion is 2017-07-30.
What interventions are being tested in trial NCT03630094?
The interventions under investigation include: FEP-ZID (DRUG).
Who is sponsoring clinical trial NCT03630094?
This trial is sponsored by Wockhardt, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.